| scholarly article | Q13442814 |
| P356 | DOI | 10.1113/JP270101 |
| P698 | PubMed publication ID | 25665036 |
| P50 | author | Shea Ping Yip | Q40246343 |
| P2093 | author name string | John A Rudd | |
| Benjamin Y Yung | |||
| Bjorn T Tam | |||
| Lawrence W Chan | |||
| Thomas K Sin | |||
| Parco M Siu | |||
| Michael Ying | |||
| Cesar S Wong | |||
| P2860 | cites work | Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization | Q24292930 |
| The anthracyclines: will we ever find a better doxorubicin? | Q28184842 | ||
| Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan | Q28203572 | ||
| Doxorubicin-induced carbonylation and degradation of cardiac myosin binding protein C promote cardiotoxicity | Q28306329 | ||
| Daunomycin-induced cardiotoxicity in children and adults. A review of 110 cases | Q28330575 | ||
| Sirtuin 1 (SIRT1) activation mediates sildenafil induced delayed cardioprotection against ischemia-reperfusion injury in mice | Q28539039 | ||
| Resveratrol improves cardiac contractility following trauma-hemorrhage by modulating Sirt1 | Q28567865 | ||
| Protective effect of caspase inhibition on compression-induced muscle damage | Q28583919 | ||
| Resveratrol induces apoptosis by directly targeting Ras-GTPase-activating protein SH3 domain-binding protein 1 | Q30009351 | ||
| SIRT1 mediates the protective function of Nkx2.5 during stress in cardiomyocytes | Q33288803 | ||
| Downregulation of Sirt1 as aging change in advanced heart failure | Q33960005 | ||
| Recommendations for chamber quantification | Q34491436 | ||
| Analysis of skeletal muscle gene expression patterns and the impact of functional capacity in patients with systolic heart failure | Q34781822 | ||
| Effects of short-term endurance exercise training on acute doxorubicin-induced FoxO transcription in cardiac and skeletal muscle | Q35141318 | ||
| Inhibition of AMP-activated protein kinase α (AMPKα) by doxorubicin accentuates genotoxic stress and cell death in mouse embryonic fibroblasts and cardiomyocytes: role of p53 and SIRT1. | Q35868154 | ||
| Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor | Q36086859 | ||
| Different effects of resveratrol on dose-related Doxorubicin-induced heart and liver toxicity. | Q36467387 | ||
| Heart transplant survival outcomes for adriamycin-dilated cardiomyopathy | Q36585760 | ||
| Supervillin-mediated suppression of p53 protein enhances cell survival | Q36685259 | ||
| Chemosensetizing and cardioprotective effects of resveratrol in doxorubicin- treated animals | Q36922988 | ||
| TNF induction of atrogin-1/MAFbx mRNA depends on Foxo4 expression but not AKT-Foxo1/3 signaling. | Q36955861 | ||
| A therapeutic dose of doxorubicin activates ubiquitin-proteasome system-mediated proteolysis by acting on both the ubiquitination apparatus and proteasome. | Q37124125 | ||
| Quantitative proteomic study identified cathepsin B associated with doxorubicin-induced damage in H9c2 cardiomyocytes. | Q38492572 | ||
| Protective effect of resveratrol against doxorubicin-induced cardiac toxicity and fibrosis in male experimental rats | Q42705162 | ||
| Sesamin ameliorates doxorubicin-induced cardiotoxicity: involvement of Sirt1 and Mn-SOD pathway | Q42708512 | ||
| Doxorubicin induces protein ubiquitination and inhibits proteasome activity during cardiotoxicity | Q42711541 | ||
| Recombinant human interleukin-1 receptor antagonist protects mice against acute doxorubicin-induced cardiotoxicity | Q42989370 | ||
| SIRT1 activation by curcumin pretreatment attenuates mitochondrial oxidative damage induced by myocardial ischemia reperfusion injury | Q43664767 | ||
| Modulating effect of SIRT1 activation induced by resveratrol on Foxo1-associated apoptotic signalling in senescent heart | Q44050017 | ||
| Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway | Q46079892 | ||
| Atrogin-1 ubiquitin ligase is upregulated by doxorubicin via p38-MAP kinase in cardiac myocytes | Q46696596 | ||
| Induction of protein degradation in skeletal muscle by a phorbol ester involves upregulation of the ubiquitin-proteasome proteolytic pathway | Q46847190 | ||
| Use of resveratrol to improve the effectiveness of cisplatin and doxorubicin: study in human gynecologic cancer cell lines and in rodent heart. | Q53625213 | ||
| Daunorubicin therapy is associated with upregulation of E3 ubiquitin ligases in the heart. | Q54530203 | ||
| Resveratrol attenuates doxorubicin-induced cellular damage by modulating nitric oxide and apoptosis | Q57116600 | ||
| Elevated p53 expression is associated with dysregulation of the ubiquitin-proteasome system in dilated cardiomyopathy | Q80979295 | ||
| Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in mice through SIRT1-mediated deacetylation of p53 | Q83324440 | ||
| P407 | language of work or name | English | Q1860 |
| P577 | publication date | 2015-01-13 | |
| P1433 | published in | Journal of Physiology | Q7743612 |
| P1476 | title | Resveratrol protects against doxorubicin-induced cardiotoxicity in aged hearts through the SIRT1-USP7 axis |
| Q33659224 | Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer |
| Q37286660 | Anthocyanin Attenuates Doxorubicin-Induced Cardiomyotoxicity via Estrogen Receptor-α/β and Stabilizes HSF1 to Inhibit the IGF-IIR Apoptotic Pathway |
| Q39370677 | Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs |
| Q47115527 | Epigenetic Regulatory Mechanisms Induced by Resveratrol. |
| Q32183971 | Ginkgolide B Exerts Cardioprotective Properties against Doxorubicin-Induced Cardiotoxicity by Regulating Reactive Oxygen Species, Akt and Calcium Signaling Pathways In Vitro and In Vivo |
| Q64094617 | Leveraging the Cardio-Protective and Anticancer Properties of Resveratrol in Cardio-Oncology |
| Q37641769 | MicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat. |
| Q55279184 | Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging. |
| Q38654368 | Prophylactic supplementation of resveratrol is more effective than its therapeutic use against doxorubicin induced cardiotoxicity. |
| Q45827486 | Regulation of Sirtuin-Mediated Protein Deacetylation by Cardioprotective Phytochemicals. |
| Q28553008 | Resveratrol Reverses Functional Chagas Heart Disease in Mice |
| Q64269543 | Resveratrol alleviates hypoxia/reoxygenation injury‑induced mitochondrial oxidative stress in cardiomyocytes |
| Q26801409 | Resveratrol, a polyphenol phytoalexin, protects against doxorubicin-induced cardiotoxicity |
| Q36196509 | SIRT1-dependent myoprotective effects of resveratrol on muscle injury induced by compression. |
| Q64063306 | The Potential Beneficial Effects of Resveratrol on Cardiovascular Complications in Marfan Syndrome Patients⁻Insights from Rodent-Based Animal Studies |
| Q58721800 | The polyphenol resveratrol promotes skeletal growth in mice through a sirtuin 1-bone morphogenic protein 2 longevity axis |
| Q55253639 | Tongguan Capsule Mitigates Post-myocardial Infarction Remodeling by Promoting Autophagy and Inhibiting Apoptosis: Role of Sirt1. |
Search more.